Search research articles
Contact Us
Filters
Showing results (91-100 of 139) with videos related to
Page
of 14
Sort By:
Cancer Discovery
|
November 20, 2023
ESR1 F404 Mutations and Acquired Resistance to Fulvestrant in ESR1-Mutant Breast Cancer
Belinda Kingston, Alex Pearson, Maria Teresa Herrera-Abreu, et al.
The New England Journal of Medicine
|
October 23, 2018
Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer
Nicholas C Turner, Dennis J Slamon, Jungsil Ro, et al.
Cancer Discovery
|
May 2, 2025
MANIFEST: Multiomic Platform for Cancer Immunotherapy
Kok Haw Jonathan Lim, Zayd Tippu, Pippa G Corrie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 24, 2006
FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas
Jorge Sergio Reis-Filho, Pete T Simpson, Nicholas C Turner, et al.
Cancer Research
|
March 30, 2016
Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor-Positive Breast Cancer
Maria Teresa Herrera-Abreu, Marta Palafox, Uzma Asghar, et al.
NPJ Breast Cancer
|
March 2, 2019
<i>ESR1</i> mutations in metastatic lobular breast cancer patients
Christine Desmedt, Julien Pingitore, Françoise Rothé, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 6, 2018
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
Jason D Merker, Geoffrey R Oxnard, Carolyn Compton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2022
Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2- ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study
Massimo Cristofanilli, Hope S Rugo, Seock-Ah Im, et al.
JCO Oncology Practice
|
June 18, 2026
Circulating Tumor DNA Testing in Solid Tumors and Lymphoma: ASCO Guideline
Christina M Lockwood, Hans J Messersmith, Annette S Kim, et al.
Archives of Pathology & Laboratory Medicine
|
March 6, 2018
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
Jason D Merker, Geoffrey R Oxnard, Carolyn Compton, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 139) with videos related to
Sort By:
Page
of 14
Cancer Discovery
|
November 20, 2023
ESR1 F404 Mutations and Acquired Resistance to Fulvestrant in ESR1-Mutant Breast Cancer
Belinda Kingston, Alex Pearson, Maria Teresa Herrera-Abreu, et al.
The New England Journal of Medicine
|
October 23, 2018
Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer
Nicholas C Turner, Dennis J Slamon, Jungsil Ro, et al.
Cancer Discovery
|
May 2, 2025
MANIFEST: Multiomic Platform for Cancer Immunotherapy
Kok Haw Jonathan Lim, Zayd Tippu, Pippa G Corrie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 24, 2006
FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas
Jorge Sergio Reis-Filho, Pete T Simpson, Nicholas C Turner, et al.
Cancer Research
|
March 30, 2016
Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor-Positive Breast Cancer
Maria Teresa Herrera-Abreu, Marta Palafox, Uzma Asghar, et al.
NPJ Breast Cancer
|
March 2, 2019
<i>ESR1</i> mutations in metastatic lobular breast cancer patients
Christine Desmedt, Julien Pingitore, Françoise Rothé, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 6, 2018
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
Jason D Merker, Geoffrey R Oxnard, Carolyn Compton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2022
Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2- ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study
Massimo Cristofanilli, Hope S Rugo, Seock-Ah Im, et al.
JCO Oncology Practice
|
June 18, 2026
Circulating Tumor DNA Testing in Solid Tumors and Lymphoma: ASCO Guideline
Christina M Lockwood, Hans J Messersmith, Annette S Kim, et al.
Archives of Pathology & Laboratory Medicine
|
March 6, 2018
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
Jason D Merker, Geoffrey R Oxnard, Carolyn Compton, et al.
Page
of 14